Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Persica Pharmaceuticals Ltd. has delivered positive 12-month follow-up data from its phase Ib study of PP-353, an injectable antibiotic for treating chronic lower back pain, and is now looking for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results